Publication | Closed Access
VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease
35
Citations
31
References
1998
Year
OncologyPathologyTherapeutic EfficacySalvage Intensification ProgramPharmacotherapyImmunosuppressionMedicineRefractory Hodgkin ’
| Year | Citations | |
|---|---|---|
Page 1
Page 1